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and Dimos Baltas1,3
We consider the inverse planning problem in brachytherapy, i.e. the problem to determine an optimal number of catheters,
number of sources for low-dose rate brachytherapy (LDR) and the optimal dwell times for high-dose rate brachytherapy (HDR)
necessary to obtain an optimal as possible dose distribution.
Starting from the 1930s, inverse planning for LDR brachytherapy used geometrically derived rules to determine the optimal
placement of sources in order to achieve a uniform dose distribution of a specific level in planes, spheres and cylinders. Rules
and nomograms were derived which still are widely used.
With the rapid development of 3D imaging technologies and the rapidly increasing computer power we have now entered the
new era of computer-based inverse planning in brachytherapy. The inverse planning is now an optimisation process adapted
to the individual geometry of the patient. New inverse planning optimisation algorithms are anatomy-based that consider the
real anatomy of the tumour and the organs at risk (OAR). Computer-based inverse planning considers various effects such as
stability of solutions for seed misplacements which cannot ever be solved analytically without gross simplifications.
In the last few years multiobjective (MO) inverse planning algorithms have been developed which recognise the MO
optimisation problem which is inherent in inverse planning in brachytherapy. Previous methods used a trial and error
method to obtain a satisfactory solution. MO optimisation replaces this trial and error process by presenting a representative
set of dose distributions that can be obtained. With MO optimisation it is possible to obtain information that can be used to
obtain the optimum number of catheters, their position and the optimum distribution of dwell times for HDR brachytherapy.
For LDR brachytherapy also the stability of solutions due to seed migration can also be improved. A spectrum of alternative
solutions is available and the treatment planner can select the solution that best satisfies the clinical constraints.
The inverse planning now can be extended to include characteristics of the radioactive sources that can be used for further
improving the dose distributions that can be obtained leading to a generalized inverse planning. The computer-based inverse
planning provides solutions that protect the OARs and the normal tissue better than by empirical methods.
We present computer-based inverse planning algorithms used for LDR brachytherapy and currently also for HDR
brachytherapy.
Planowanie odwrócone w brachyterapii
W pracy omówiono problem odwróconego planowania w brachyterapii. Planowanie odwrócone ma na celu okreÊlenie
optymalnej liczby prowadnic i êróde∏ promieniowania w brachyterapii niskimi mocami dawki (LDR) oraz w∏aÊciwy czas
pozostawania êród∏a promieniowania w prowadnicach (dwell time) celem uzyskania najlepszej mo˝liwej dystrybucji dawek
promieniowania w brachyterapii wysokimi mocami dawki (HDR).
Dzieje planowania odwróconego si´gajà lat trzydziestych XX wieku. Poczàtkowo polega∏o ono na zastosowaniu zasad
geometrii celem okreÊlenia punktu, w którym nale˝a∏o umieÊciç êród∏o promieniowania aby uzyskaç najkorzystniejszà
dystrybucj´ dawek pomi´dzy poszczególnymi wyliczonymi p∏aszczyznami, kulami i cylindrami. Z tamtego wczesnego okresu
wywodzà si´ zasady post´powania i nomogramy u˝ywane do dnia dzisiejszego.
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Introduction
The term inverse problem is a well known mathematical
term dating at least from the 19th century [1, 2] and there
are several mathematical journals devoted to this topic.
What is meant in simplistic terms: first you know the
ideal answer, and second you take into account any
constraints and mathematically determine the optimum
parameter values to provide the ideal answer. In other
words you have the result and the inverse problem is to
determine the cause of this result. We have to solve
inverse problems in geophysical studies and medical
applications where it is often desired to find out
the internal unknown structure of an object using
measurements performed outside the object, that is, non-
invasively. This can be done e.g. by measuring radiation,
X-ray, ultrasound etc, or acoustic waves that passes
through the object. The object under study can be e.g.
the human body, or the earth crust.
An inverse problem for conformal anatomy-based
brachytherapy is the problem of the complete coverage of
the PTV with a dose at least equal to the prescription
dose. Simultaneously dose values above specific values
should be avoided in OARs and the surrounding normal
tissue (NT).
A major quantity of interest in brachytherapy is the
dose D(r)=D(x,y,z) at a point r in the treatment volume.
The dose distribution specifies the corresponding three-
dimensional non-negative scalar field
(1)
The dependence between energy fluence Ψ and dose
distribution D, A⋅Ψ= D, is given by the energy absorption
per mass and energy fluence unit operator A or energy
absorption operator which describes the local energy
dissipation for a given patient anatomy.
We term the mapping process from the source
distribution to the dose distribution, the dose operator.
A dose distribution is possible if there is a source distri-
bution which is able to generate it. This depends on which
source distributions can be achieved by the catheters,
source dwell positions (SDP), etc.
The dose space {D} defines the space of all
achievable dose distributions for a given patient anatomy
and consequently the set of all possible energy fluences
defines the fluence space {Ψ}. The physical and biological
characteristics of the patient anatomy and of the source
are used for the calculation of the dose function, i.e. the
absorbed dose as a function of the location in the body.
A physician, depending on the patient, prescribes
the so called desired dose function. The objectives are to
deliver a sufficient high dose in the cancerous tissue and
to protect the surrounding normal tissue (NT) and organs
at risk (OAR) from excessive radiation.
While the determination of D from Ψ, the solution
of the so-called forward problem, is possible the inverse
problem, i.e. determination of Ψ for a given D is not
always possible. The forward problem is the dose cal-
culation problem for which a unique solution exists.
Even if A can in principle be inverted, the image of
A-1D will not be always an element of {Ψ} and it is
possible that the solution is not unique. This problem
can be solved analytically only for very simple cases, see
Figure 1.
In reality only solutions are interesting if they have
a realistic number of sources inside a realistic and if
possible small number of catheters. In HDR brachy-
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Szybki rozwój trójwymiarowych technik obrazowania przebiegajàcy z jednoczesnym post´pem w dziedzinie informatyki
umo˝liwi∏ komputerowe planowanie odwrócone. W chwili obecnej planowanie odwrócone to proces majàcy na celu
optymalizacj´ post´powania w zale˝noÊci od indywidualnej geometrii poszczególnych guzów. Nowe algorytmy stosowane
w planowaniu odwróconym opierajà si´ na zasadach anatomii – tak samego guza jak i otaczajàcych go narzàdów krytycznych
(organs at risk – OAR). Algorytmy te uwzgl´dniajà równie˝ takie elementy jak g´stoÊç tkanek warunkujàca rozproszenie dawki,
co nie mog∏o byç w ˝aden sposób okreÊlone analitycznie bez zastosowania znacznych uproszczeƒ.
W ciàgu ostatnich lat pojawi∏y si´ równie˝ wielop∏aszczyznowe algorytmy planowania odwróconego (Multiobjective Inverse
Planning Algorithms – MO). Uwzgl´dniajà one wiele zagadnieƒ nierozerwalnie zwiàzanych z problemami planowania
wstecznego w brachyterapii. Metody stosowane wczeÊniej opiera∏y si´ na zasadzie prób i b∏´dów, co prowadzi∏o stopniowo do
uzyskania najlepszego mo˝liwego rozk∏adu dawek. Technika MO zast´puje powtarzanà seri´ prób i b∏´dów przedstawieniem
mo˝liwych do uzyskania zakresów dystrybucji dawek. Umo˝liwia to z kolei okreÊlenie optymalnej liczby zastosowanych
prowadnic, ich najlepszego umiejscowienia i najskuteczniejszych czasów pozostawania êróde∏ promieniowania w prowadnicach
w brachyterapii metodà HDR. W przypadku metody LDR technika MO umo˝liwia okreÊlenie g´stoÊci tkanek warunkujàce
rozproszenie dawek. Systemy planowania oparte na technice MO przedstawiajà serie mo˝liwych rozwiàzaƒ, jak równie˝
posiadajà funkcj´ samodzielnego wyboru rozwiàzania najbardziej odpowiedniego w danej sytuacji klinicznej.
Planowanie odwrócone mo˝e obecnie byç wzbogacone o charakterystyk´ poszczególnych êróde∏ promieniowania, co z kolei
prowadzi do dalszego ulepszenia dystrybucji dawek. Wreszcie komputerowo przeprowadzone planowanie odwrócone dostarcza
rozwiàzaƒ umo˝liwiajàcych lepszà ochron´ pobliskich narzàdów (OAR) i tkanek ni˝ wczeÊniej stosowane techniki empiryczne.
W pracy przedstawione zosta∏y algorytmy planowania odwróconego z zastosowaniem techniki komputerowej stosowane tak
w brachyterapii niskimi (LDR) jak i wysokimi mocami dawek (HDR).
Key words: brachytherapy, inverse planning
S∏owa kluczowe: brachyterapia, planowanie odwrócone
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therapy, dwell positions are typically spaced up to 1 cm
apart and dwell times are usually in the range of a second
to a minute per dwell position. HDR procedures such as
for bronchial cancer require only a single catheter and
several dwell positions. Others, such as breast implants,
may involve several hundred dwell positions. In interstitial
breast or prostate implants some 20 catheters may be
used.
As an analytical solution cannot be obtained we
consider the inverse problem to determine the position
and number of SDPs or sources, number of catheters and
for HDR brachytherapy the dwell times, such that the
obtained dose distribution satisfies as much as possible
the desired dose function via an optimisation process.
This process is called inverse optimisation or inverse
planning. It includes clinical constraints such as a realistic
range of catheters and the possible positions and orien-
tations of the catheters. It is the procedure where the
ideal implant is imaged in a virtual environment. This is
based on 3D imaging which may involve CT, MR or ultra-
sound, and on anatomy contouring and template/catheter
information. This virtual implant forms the basis for the
real implant, where physicians try to work as closely as
possible to obtain this virtual implant.
The determination of an optimal number of
catheters is a very important aspect of inverse planning, as
a reduction of the number of catheters simplifies the
treatment plan in terms of time and complexity. It also
reduces the possibility of treatment errors and is less
invasive for the patient.
If the positions and number of catheters and the
SDPs are given after the implantation of the catheters in
HDR brachytherapy, we term the process post-planning.
Then, the optimisation process to obtain an optimal dose
distribution is called dose optimisation. Dose optimisation
can be considered as a special type of inverse optimisation
where the positions and number of catheters and the
SDPs are fixed.
Inverse planning in brachytherapy is not a new
concept and has been studied for more than 70 years.
The reasons why this has only relatively recently become
a topic for widespread study, is due to technological
advances both in computing power (analogue computing
devices were never satisfactory) and in imaging
possibilities in 3D such as with CT [3-5] MR [6] and
ultrasound [7] This allows very accurate localization of the
prostate tumour, the OARs and the applicators [8-10].
Only currently this information is used with new
dose optimisation algorithms which are termed anatomy-
based [11-13]. The exponential growth of computing
power of standard personal computers together with
specialized optimisation algorithms now permits real time
dose optimisation.
Only recently the multiobjective nature of dose
optimisation and inverse planning has been recognized
and multiobjective optimisation algorithms now provide
information of the trade-off between the objectives and
the limitations on the physical possible dose distributions.
A spectrum of possible solutions is obtained and the
treatment planner can now obtain, semi-automatically or
automatically, not only a satisfactory solution but also
the best solution with the least compromise on all
objectives considered simultaneously. This improves the
quality of the dose distributions by reducing the
unnecessary dose to the smallest possible level by
considering the objective functions, the anatomy and the
topology of the applicators. This increases the probability
of treatment success and minimizes the complication
probability for the healthy surrounding tissue and the
OARs.
Only seed LDR brachytherapy is considered, with
radionuclides such as 125I and 103Pd, because the earlier
methods of LDR manual afterloading of linear sources
with radionuclides such as 226Ra, 182Ta and 192Ir are no
longer used. With HDR brachytherapy the source used
is the single 192Ir source of the remote controlled
Figure 1. Forward and inverse problem in radiotherapy: The sets {Ψ*} and {D*} are all possible fluence and dose distributions
respectively which include the corresponding physical possible distributions {Ψ} and {D}. The determination of a fluence
distribution from a desired optimal dose distribution Dopt is not always possible, such as for the two physical possible dose
distributions D1 and D2 because the corresponding fluence distribution Ψopt may not be an element of {Ψ}
afterloading machine which can take various dwell
positions.
For LDR brachytherapy the problem is to determine
the optimal position of the permanent sources (e.g. 125I
seeds for prostate implantation) and their number. In
practice, seed sources are seldom implanted at the exact
planned position due to technical difficulty and also they
can move after the implantation. This misplacement
obviously has a negative impact on the treatment quality.
However, there is no possibility to control the LDR
results unlike in HDR brachytherapy when dwell times
can be modified.
We discuss only the situation where each LDR seed
or HDR source dwell is inserted into catheters using
a template. We term the inverse planning with this
constraint template-based inverse planning. Template
techniques are now the norm in clinical practice and
therefore free-hand implants as well as being more
difficult for inverse planning are not as relevant as
template-based implants.
This review is divided into the topics listed in Table I.
Table I. Topics discussed in this review
Optimisation
O p t i m i s a t i o n  o b j e c t i v e s
M u l t i o b j e c t i v e  o p t i m i s a t i o n
S i n g l e  o b j e c t i v e  o p t i m i s a t i o n
D e c i s i o n  m a k i n g
O p t i m i s a t i o n  a l g o r i t h m s
Linear and integer programming
Simulated annealing
Evolutionary algorithms
Multiobjective evolutionary methods
LDR brachytherapy
T h e  s t a r t  o f  L D R  i n v e r s e  p l a n n i n g  i n  t h e  1 9 3 0 s
C u r r e n t  t h e o r e t i c a l  s t u d i e s  f o r  L D R
b r a c h y t h e r a p y
S t r a t e g y  o p t i o n s  f o r  L D R  b r a c h y t h e r a p y
C o m p u t e r - b a s e d  i n v e r s e  p l a n n i n g  f o r  L D R
b r a c h y t h e r a p y
Iterative geometric optimisation
Inverse planning with simulated annealing
Inverse planning with evolutionary algorithms
Decision steered algorithm
Inverse planning with mixed integer programming
HDR brachytherapy
E m p i r i c a l  l o a d i n g  m e t h o d s
C o m p u t e r  b a s e d  m e t h o d s
Multiobjective evolutionary inverse planning
Hybrid evolutionary multiobjective optimisation
Encoding
Genetic operators
I s  i n v e r s e  p l a n n i n g  f o r  H D R  b r a c h y t h e r a p y  r e a l l y
n e c e s s a r y ?
W h a t  c a n  w e  l e a r n  f r o m  m u l t i o b j e c t i v e  i n v e r s e
p l a n n i n g ?
Optimal sources for optimal results
Optimisation
O p t i m i s a t i o n  o b j e c t i v e s
An ideal dose function D(r) with a specific prescription
dose Dref is:
(2)
This dose distribution is not obtainable since radiation
can not be confined to the planning target volume (PTV)
only and some part of the radiation has to traverse the
OARs and the surrounding normal tissue (NT).
Out of all possible dose distributions the problem
is to obtain the optimal dose distribution without any
a priori knowledge of the physical restrictions. Optimality
requires quantifying the quality of a dose distribution. 
A natural measure quantifying the similarity of
a dose distribution at N sampling points with dose values
di to the corresponding optimal dose values di* is
a distance measure. A common measure is the Lp norm.
(3)
For p = 2, i.e. L2 we have the Euclidean distance.
The dose optimisation problem is transformed into
an optimisation problem by introducing as an objective
the minimization of the distance between the ideal and
the achievable dose distribution. These objectives can be
expressed in general by the objective functions fL(x) and
fH(x)
(4)
(5)
where di(x) is the dose at the ith sampling point that
depends on parameters x such as dwell times, p is
a parameter defining the distance norm, N the number of
sampling points, DL and DH the low and high dose limits.
These are used if dose values below DL and above DH
are to be ignored expressed by the step function Θ(x).
The difference between various dosimetric based
objective functions is the norm used for defining the
distance between the ideal and actual dose distribution,
on how the violation is penalized and what dose
normalization is applied. For p=2 we obtain the quadratic
type of objectives [14], for p=1 a linear form [13]. For
p=0 [12] the DVH-based objectives as the DVH value
at the dose DH is given by
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(6)
Another method is to use dose-volume histogram
(DVH) specifying constraints. These can be used for
a constraint dose optimisation. Such constraints could
specify upper bounds for the fraction of the volume of
a region that can accept a dose larger than a specific
level, or a lower bound for the fraction that should have
a dose at least larger than a specific value.
Different dose distributions can be obtained if only
DVH-based objectives are considered as the dose
distributions are only required to satisfy some integral
properties. This could be a benefit if we want to obtain
a large range of possible dose distributions. It can also be
a reason that various optimisation algorithms can not be
used for dose optimisation.
M u l t i o b j e c t i v e  o p t i m i s a t i o n
Inverse planning for brachytherapy has to consider many
objectives and is thus a multiobjective (MO) problem.
We have competing objectives. Increasing the dose in the
PTV will increase the dose outside the PTV. A trade-off
between the objectives exist and we never have a situation
in which all the objectives can be in a best possible way be
satisfied simultaneously.
MO optimisation provides in dose optimisation the
information of all possibilities of alternative solutions we
can have for a given set of objectives. By analysing the
spectrum of solutions we have to decide which of these
are the most appropriate according to the treatment and
our clinical aims. The two steps are to solve the MO
problem and decide what the optimal solution is.
The MO problem (also called multicriteria optimisa-
tion or vector optimisation), can be defined as the
problem of determining the following. "A vector of
decision variables which satisfies constraints and optimises
a vector function whose elements represent M objective
functions. These functions form a mathematical de-
scription of performance criteria that are usually in
conflict with each other. Hence optimises means finding
a solution which would give the values of all objective
functions acceptable to the treatment planner." [15].
We call decision variables xj, j=1,...,N for which
values are to be chosen in an optimisation problem. For
LDR brachytherapy these variables could specify which
catheters and source positions should be considered. In
HDR brachytherapy the dwell times have to be included
in the set of decision variables.
In order to know how good is a certain solution, we
need to have some criteria for evaluation. These criteria
are expressed as computable functions f1(x),...,fM(x) of
the decision variables, which are called objective functions.
These form a vector function f = (f1(x),...,fM(x). In
general, some of these will be in conflict with others, and
some will have to be minimized while others are
maximized. The multiobjective optimisation problem can
be now defined as the problem to find the vector
x=(x1,x2,...,xN), i.e. solution which optimise the vector
function f.
The constraints define the feasible region X and any
point x in X defines a feasible solution. The vector
function f(x) is a function that maps the set X in the set F
that represents all possible values of the objective
functions. Normally we never have a situation in which all
the fi(x) values have an optimum in X at a common point
x. We therefore have to establish certain criteria to
determine what would be considered an optimal solution.
One interpretation of the term optimum in multiobjective
optimisation is the Pareto optimum, see Figure 2.
A solution x1 dominates a solution x2 if and only if
the two following conditions are true:
DVH D
N
d D100H i H
i
N
1
= -H
=
_ _i i!
Figure 2. Example of a bi-objective space (f1, f2). We assume a minimization problem. (a) The Pareto front is the boundary between the points P1
and P2 of the feasible set F. Solutions 1 and 3 are non-dominated Pareto optimal solutions. Solution 2 is not Pareto optimal as solution 1 has
simultaneously smaller values for both objectives. There is no reason why solution 2 should be accepted rather than solution 1. Therefore the aim of
MO optimisation is to obtain a representative set of non-dominated solutions. (b) The ideal and anti-ideal or nadir point I and A respectively. The
point A+ defined by Yu et al [16] as anti-ideal is defined over the whole F range, whereas the points I and A are defined by the set of efficient points
Figure 2a Figure 2b
– x1 is no worse than x2 in all objectives, i.e. fj(x1)  fj(x2) ∀
j=1,...,M.
– x1 is strictly better than x2 in at least one objective, i.e.
fj(x1) < fj(x2) for at least one j ∈ {1,...,M}.
We assume, without loss of generality, that this is
a minimization problem. x1 is said to be non-dominated
by x2 or x1 is non-inferior to x2 and x2 is dominated by x1.
Among a set of solutions P, the non-dominated set of
solutions P' are those that are not dominated by any other
member of the set P, see Figure 2(a). When the set P is
the entire feasible search space then the set P' is called the
global Pareto optimal set. If for every member x of a set P
there exists no solution in the neighbourhood of x then
the solutions of P form a local Pareto optimal set. The
image f(x) of the Pareto optimal set is called the Pareto
front, see Figure 2(a). The Pareto optimal set is defined in
the parameter space, while the Pareto front is defined in
the objective space.
For inverse planning each solution will have
a corresponding set of catheters to be selected and their
number is additional to the dwell times for the SDPs of
the selected catheters.
The ideal point and the nadir or anti-ideal point are
characterized by the components of the best and worse
objective values of efficient points respectively, see Figure
2(b).
S i n g l e  o b j e c t i v e  o p t i m i s a t i o n
In single objective optimisation only one objective fun-
ction is considered. Although inverse planning is a MO
optimisation problem the majority of optimisation
algorithms in brachytherapy are single objective opti-
misation algorithms. The M objective functions fm(x) are
combined into a single objective function f(x), e.g. by
using a weighted sum of all objectives.
(7)
The weights wm are also known as importance factors
and are considered as a measure of the significance of
each objective in the optimisation process. A repre-
sentative convex part of the Pareto set can be sampled by
running a single objective optimisation algorithm each
time with a different vector of importance factors.
We call a set of importance factors vectors normalized
and uniformly distributed if each importance factor of
each objective takes one of the following values:
[l/k,l=0,1...,k], where k is the sampling parameter and
for each vector w.
For two objectives the weighted sum is given by
(8)
The minimization of the weighted sum can be
interpreted as finding the value of y for which the line
with slope – w1/w2 just touches the boundary of F as it
proceeds outwards from the origin. If x* is a Pareto
optimal solution then there exists a weight vector
w=(w1,w2,...,wM), such that x* is a solution of the
multiobjective convex optimisation problem.
Figure 3 shows an example for a weighted sum
optimisation for a bi-objective problem. The solution
obtained by (w1,w2) is the non-dominated solution P. If the
value f1 is not satisfactory then we can increase the
importance factor w1 to w1*. The new set of importance
factors (w1*,w2) specify a new direction and the solution is
P*. The value of f1 of P* is smaller but the value f2(P*) is
larger than f2(P). If we are not satisfied by the value of
f2(P) we can try another importance factor w1** with
w1*>w1**>w1.
In a trial and error method the optimisation is
repeated with different importance factors until the
treatment planner considers that the optimisation result is
acceptable. The planner by a trial and error method
determines the structure of the Pareto front.
While for two objectives a solution very close to the
optimal can be found it is more difficult as more
objectives are considered. The complexity of the Pareto
front increases rapidly and also the combinatorial
complexity. To determine the dependence of the results
on the importance factors with a sufficient accuracy
requires repeating the optimisation a large number of
times with different importance factor combinations. The
solution which is obtained in the conventional weighted
sum approach depends on the shape of the Pareto front
and the importance factors used.
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Figure 3. Single objective weighted sum optimisation w1 f1 + w2 f2 for
a bi-objective problem. For a given set of importance factors the vector
sum of w1, w2, if we consider these as vectors, specifies a direction S
shown by the dashed line. The optimisation provides a solution which is
the point P of a line perpendicular to the direction S that will touch the
Pareto front as the line is moved away from the origin along S. Solution
P* will be obtained if we replace w1 by a larger importance factor w1*
D e c i s i o n  m a k i n g
Multiobjective optimisation requires a decision making
process as there is not a single solutions but a set of non-
dominated solutions out of which the best must be
chosen. Three strategies can be used.
– An a priori method. The decision making (DCM) is
specified in terms of a scalar function and an optimisa-
tion engine is used to obtain the corresponding
solution.
– An a posteriori method. An optimisation engine exists
which finds a representative set of all solutions.
Decision making is applied at the end of the op-
timisation manually, or using a decision engine. This
method decouples the solutions from the decision
making process. A new decision is possible without
having to repeat the optimisation.
– Mixture of a priori and a posteriori methods. During the
optimisation periodically information can be used
which may be used to reformulate the goals as some of
these can physically not be achieved.
The non-dominated solutions provide information
on the trade-off between the objectives. This trade-off is
described by the form of the Pareto front. In Figure 4
two different forms of trade-offs are shown.
In Figure 4(a) there is a strong trade-off between
the objective f1 and f2. The smaller the f1 value is that we
want the larger is the corresponding f2 value. We can see
how much this depends on the choice of f1. There is
a weak trade-off between f1 and f2 in Figure 4(b). It is
possible to minimize f1 significant and close to the ideal
point (f1,min, f2,min). Only very close to f1,min we see a rapid
increase of f2. This is a case for a set of parameters for
which we can obtain simultaneously almost the individual
optimal values for f1 and f2. The Pareto front provides
also ranges of objective values.
For more than two objectives the trade-off can be
difficult to analyse graphically. A sensitivity analysis can
be performed numerically such that it considers the local
slope of the Pareto front as a measure of the trade-off.
The main two tasks of MO optimisation are
– Obtaining a representative set of non-dominated
solutions.
– Selecting a solution from this set, i.e. the decision
making process.
For MO optimisation decision-making tools are
necessary to filter a single solution from the non-
dominated set that matches at best the goals of the
treatment planner.
DCM tools have been developed for the Real-Time
HDR prostate planning system SWIFTTM (Nucletron
B.V., Veenendaal, The Netherlands). A display table of
a list of values for all solutions of the objectives, COIN,
DVHs for all OARs, the NT and the PTV of each
solution is provided. Other parameters are D90 (dose that
covers 90% of the PTV), V150 (percentage of the PTV
that receives more than 150% of the prescription dose).
Additionally, the extreme dose values are also
provided. The entire table for every such quantity can
then be sorted and solutions can be selected and
highlighted by the treatment planner. Constraints can
then be applied such as to show only solutions with a PTV
coverage value 100c1 larger than a specified value. The
PTV coverage is the percentage of the PTV that receives
at least 100% of the prescription dose. Solutions that do
not satisfy the constraints are removed from the list. This
reduces the number of solutions and simplifies the
selection of an optimal solution.
The DVHs of all selected solutions can be displayed
and compared, see Figure 5.
Other decision-making tool could be the display of
projections of the Pareto front onto a pair of selected
objectives. For M objectives the number of such
projections is M(M–1)/2.
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Figure 4a
Figure 4. Trade-off between two objectives of a bi-objective problem: (a) Strong and (b) weak trade-off between f1 and f2
Figure 4b
The position of selected solutions can be seen in
these projections. This helps to identify their position in
the multidimensional Pareto front and to quantify the
degree of correlation between the objectives and of the
possibilities provided by the non-dominated set. The
Pareto front provides information such as: How much
can an objective be optimised and how this modifies the
other objectives values? What is the range of values for
each objective? The trade-off between other DVH
derived quantities can also be used to select the optimal
solution, see Figure 6.
O p t i m i s a t i o n  a l g o r i t h m s
There is no optimisation algorithm which is optimal for all
optimisation problems.
The most important single and multiobjective
optimisations algorithms used for optimisation of dose
distributions in brachytherapy are.
– D e t e r m i n i s t i c . Optimisation methods that do not
use any random elements during the optimisation.
Linear programming and quadratic programming
algorithms belong to this class.
– S t o c h a s t i c . Optimisation algorithms that use
random elements produced by the use of random
numbers. Such algorithms are evolutionary algorithms
and simulated annealing.
Linear and integer programming
In linear programming (LP) [17] certain variables should
take integer values but for the sake of convenience,
fractional values are taken assuming that the variables
are likely to be so large that any fractional part could be
neglected. While this is acceptable in some situations, in
many cases it is not, and in such cases numerical solutions
are required in which the variables take only integer
values.
Problems in which this is the situation are called
integer program problems and the subject of solving such
programs is called integer programming (IP). IPs occur
frequently because many decisions are essentially discrete
(such as yes/no, 1/0) in that one (or more) options must
be chosen from a finite set of alternatives.
For problems in which some variables can take only
integer values and some variables can take fractional
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Figure 5a
Figure 5. Example of a plot of the DVHs (a) the PTV and for (b) the urethra obtained from a representative set of non-dominated solutions. A
single solution selected by a treatment planner is shown. Its corresponding DVHs can be compared to the DVHS of the other solutions
Figure 5b
Figure 6a
Figure 6. Trade-off between DVH(Dref) for the PTV and (a) volume of urethra with overdose, (b) volume of rectum with overdose
Figure 6b
values are called mixed integer problems (MIP). The LDR
dose optimisation problem can be considered as an IP
problem where the parameters are 1 or 0 if a specified
position has to be occupied by a source or not.
As linear optimisation methods do not necessary
provide integer solutions a branch and bound method is
used [18].
The method excludes from the search parts of the
search space which cannot give better results than the
current best known solution. Upper and lower bounds
have to be specified for parameters for which no integer
solution can be found. The problem is divided recursively
forming a complex tree structure of sub-problems to be
solved until a feasible solution is found.
Simulated annealing
For objectives that are not continuous and/or in the
presence of local minima gradient-based algorithms can
not be used or produce sub-optimal results.
In analogy with a technique known in metallurgy
when a molten metal reaches a crystalline structure which
is the global minimum thermodynamic energy of the
system, if it is cooled slow enough, in simulated annealing
(SA) an artificial temperature is introduced and gradually
cooled. The parameter values (configurations) are pro-
duced randomly according to a so called visiting probability
distribution. The cooling schema depends on the visiting
probability distribution. In SA two consecutive confi-
gurations are compared. The temperature acting as
a source of noise helps the system to escape from local
minima. Near the end of the cooling process the system is
hopefully inside the attractive basin of the global
optimum. The challenge is to decrease the temperature
fast enough without any irreversible trapping at any local
minimum. The principal steps of a SA algorithm are
shown in Figure 7.
Steps 3 and 4 of the algorithm, see Figure 7, allows
to escape from local minima because not only con-
figurations will be accepted that reduce the energy but
also configurations that increase the energy (uphill
moves). This depends on the temperature T(k). As the
temperature is reduced only very small uphill moves are
accepted. The search is more localized.
Figure 7. Principal steps of an SA algorithm
Evolutionary algorithms
Evolutionary algorithm (EA) is a collective term for all
variants of probabilistic optimisation algorithms that are
inspired by Darwinian evolution.
A genetic algorithm (GA) is a variant of EA, which,
in analogy to the biological DNA alphabet, operates on
strings which are usually bit strings of constant length.
The string corresponds to the genotype of the individual.
The phenotype of the individual is obtained by a mapping
onto the object parameters (genotype-phenotype
mapping). Usually a GA has the following components:
– A representation of potential solutions to the problem.
– A method to create an initial population of potential
solutions.
– An evaluation function that plays the role of the
environment, rating solutions in term of their fitness.
– Genetic operators that alter the composition of the
population members of the next generation.
– Values of various parameters that the genetic algorithm
uses (population size, probabilities of applying genetic
operators, etc.).
In contrast to the canonical GA with bit encoded
parameters, the genome of real-coded GA consists of
real-valued object parameters, i.e. evolution operates on
the natural representation. Usually for each chromosome
an upper and lower limit of possible values is given which
reduces the size of the search space.
– Fitness is an evaluation of an individual with respect to
its reproduction capability and is usually a function of
the objective function (to be optimised), which
depends on the object parameters. The term fitness
function is often used as a synonym for objective
function.
– Selection in EA is based on the fitness. Generally, it is
determined on the basis of the objective value(s) of
the individual in comparison with all other individuals
in the selection pool. In tournament selection
a number T of individuals is chosen randomly from
the population and the best individual from this group
is selected as parent. This process is repeated as often
as individuals to choose. These selected parents ran-
domly produce uniform offspring. The parameter for
tournament selection is the tournament size T. T takes
values ranging from 2 to the number of individuals in
the population. Increasing T increases the selection
pressure, i.e. the probability of the best individual being
selected compared to the average probability of
selection of all individuals. Also the selection intensity
increases, i.e. the expected average fitness value of the
population after applying the selection method.
– Elitism is a method that guarantees that the best ever
found solution would always survive the evolutionary
process. For multiobjective optimisation elitism has to
consider that a single optimum solution does not exist
but a set of so-called non-dominated solutions.
– Crossover operators such as the simulated binary
crossover (SBX) [19] allow the parameter space to be
1. Get initial configuration S and temperature T(0) = T0,
set k=0
2. Select S' successor of S according to a visiting probability
distribution
3. Calculate ∆E = E(S') – E(S)
4. If ∆E  0 then set S = S' else set S=S' with probability
exp(-∆E/T)
5. If equilibrium at current T is reached then go to step 2
else go to step 6
6. k=k+1
7. Reduce T according to the cooling schedule T(k).
8. If stopping criterion satisfied go to step 2 else output
best solution found
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searched initially sufficiently in large steps. During the
evolution the search is limited around the current
parameter values with increasing accuracy.
– Mutation operators have been proposed for real-coded
GAs, such as the Polynomial mutation [20] and the
non-uniform mutation [21]. Mutation searches usually
in the local neighbourhood of the parent solution
whereas crossover results in a more global oriented
exploration of the search space.
An implementation of a GA begins with a popu-
lation of (typical random) chromosomes. One then
evaluates in such a way that those chromosomes which
represent a better solution to a problem are given more
chances to reproduce than those chromosomes which are
poorer solutions. The goodness of a solution is typically
defined with respect to the current population defined
by a fitness function. Figure 8 shows the principal steps
for GAs.
Figure 8. Principal steps of a genetic algorithm.
Multiobjective evolutionary methods
Single objective optimisation algorithms provide in the
ideal case only one Pareto optimal solution in one
optimisation run. Multiobjective evolutionary algorithms
(MOEAs) provide a representative set of the Pareto front.
The following problems have to be considered
– How to maintain a diverse Pareto front approximation
(Density estimation, Diversity).
– How to prevent non-dominated solutions from being
lost? (Environmental selection).
– How to guide the population towards the Pareto front?
(Mating selection).
MOEAs are mainly either aggregation or dominance
based.
– A g g r e g a t i o n  b a s e d – Non-dominated solutions
are obtained by a weighted sum of the individual
objective functions. The importance parameters can
be varied during the evolution of the population and
non-dominated solutions are acquired.
– D o m i n a n c e  b a s e d – MOEAs use in this case
the dominance relation as a measure of the fitness of
each individual. No parameters are required such as
importance factors for aggregate-based algorithms.
A representative set of a finite number of solutions
requires that the non-dominated solutions are as
uniformly as possible distributed on the Pareto front of
interest.
MOEAs can be more effective than multistart single
objective optimisation algorithms. The search space is
explored in a single optimisation run. It is easier to select
a solution if alternatives are known. Aggregation of
several objectives into a single one requires setting of
parameters. True multiobjective evolutionary algorithms
do not require importance factors.
LDR brachytherapy
T h e  s t a r t  o f  L D R  i n v e r s e  p l a n n i n g  i n
t h e  1 9 3 0 s
Although a certain amount of work had been published
earlier on the calculation of the distribution of exposure
around a finite length linear source in air by Meyer &
Schweidler (1916) [22] and Sievert (1921) [23], it was not
until the 1930s that there were many publications on this
topic which could lead to practical applications in the
hospital. The majority were related to surface brachy-
therapy applicators, but volume implants were also
considered to a certain extent.
Simple geometrical sources were considered: the
line, annulus, disc, sphere and cylinder, all with uniform
radioactive density per cm, per cm2 or per cm3, whichever
was relevant to the geometry being considered. Several
groups in the 1930s were attempting to develop a System,
including those led by Murdoch in Brussels, by Mayneord
at the Royal Cancer (later Marsden) Hospital in London,
by Souttar at the London Hospital and by Paterson at
the Christie Hospital & Holt Radium Institute in
Manchester [24]. With hindsight we now know that
Manchester won but it was not immediately apparent in
the early 1930s that this would be the result.
The calculations started with the point source as
a basic radioactive element of the geometry being
considered. Then using the inverse square law and the
k-factor for radium (in units of röntgen per hour per
milligram at 1 cm) the exposure rate (X) at a distance r
cm for a milligram radium point source was given by
X = k/r2 röntgen / hour (9)
One of the great debating points in the literature
of 1930s was the numerical value of k, with the value of
9.0 R/hr/mgm used by Mayneord [25] and others from
1932, becoming 8.4 in the Manchester system [26] in 1967
for a point source filtered by 0.5 mm platinum. However,
by the early 1960s it had been generally agreed that it
was 8.25 and having had its name changed to specific
gamma-ray constant (Γ) in the 1950s, it is currently called
the exposure rate constant [27] (R/hr/mCi at 1 cm)
although with SI units what is now more often quoted is
the specific gamma-ray constant of 1.760X10-18 Ckg-1s-1
Bq-1m2 or the air kerma rate constant 0.195 µGy-1
1. Initialise population chromosome values.
2. Assign fitness for each individual.
3. Select individuals for reproduction.
4. Perform crossover between random selected pairs with
probability pC.
5. Perform mutation with probability pM.
6. Stop. If maximum generation reached or any other
stopping criterion is satisfied else go to 2.
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MBq-1m2. Mathematically the simplest linear source is
infinitely thin and unfiltered, consisting of an infinite
number of elementary linear sources (each consisting of
a number of point sources). However, practical line
sources always have a filter surrounding them to absorb
the alpha and beta radiation and of course they are also of
finite length.
If k is the k-factor, P is the point of interest in air at
a distance from the linear source, r is the linear
radioactive density, h is the perpendicular distance from
the source to point P and Xp is the exposure at P the Xp is
given by the equation
röntgen / hour (10)
Where the functions Fn(Θ) which have been tabulated by
Sievert [23, 28] over a wide range of parameters are
known as the Sievert integrals, where
(11)
and µ is the linear attenuation coefficient of the platinum
filter. The line source of finite length a is divided into an
infinite number of elementary sources of length dx, where
the filter is an infinitely long cylinder of radius d.
Figure 9 is a schematic diagram of a filtered line
source and it can be seen that the surrounding space can
be divided into four different regions A-D which are
defined by the length of platinum filter traversed by the
radium gamma-rays. For an end-on point, Q, in region C,
where the maximum amount of platinum is traversed the
exposure rate at Q is XQ given by
(12)
where the integration limits are
and .
These Sievert integrals and the formulae given above
are the first brachytherapy algorithms and were used for
many years following the 1921 and 1932 publications of
Sievert [23, 28]. Although some authors republished the
Sievert integrals in a more convenient format for use
than the original tables, devising for example, nomograms.
Sievert did not include any self-absorption correction
to take into account the finite thickness of the radium
source and also presented the integrals only for exposure
in air and not for absorbed dose in water.
However, relatively shortly before the widespread
use of digital computers for radiotherapy planning, Young
and Batho published [30] in 1964 tables which took these
factors into account. Using a factor of 0.97 to convert
röntgens in air to rads in water they tabulated data for
some 3000 points for each of several filtrations. However,
with the availability of gamma-ray source dosimetry
calculation software such extensive tables were no longer
required and the modern era was entered.
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Figure 9. Regions of interest around a filtered linear radium source when it is required to calculate the exposure rate around the source [29]
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The algorithms for calculating the exposure
distributions in air around disc and annular sources were
more complicated than those given above for a line
source, but a judicious superposition of an annular source
of uniform radioactive density rA on a disc source of
uniform radioactive density rD a homogeneous exposure
distribution could be found at a distance (say 1 cm) from
the combination disc + annulus.
In this manner, a System could be devised for planar
surface brachytherapy applicators and this is essentially
what was proposed by Mayneord, Souttar, Paterson &
Parker and others [29].
Spherical volumes are relevant to interstitial
brachytherapy and the calculations for a System were
approached in a similar manner to that described above,
although in this instance, it was a combination spherical
shell + sphere which was considered. The aim here was to
obtain a homogeneous exposure throughout a sphere and
the problem was to define the radius of the sphere and
the thickness of the spherical shell.
One example is shown [29] in Figure 10 for a sphere
of radius s cm and uniform radioactive density
rSphere=1 Ci/cm3 combined with a spherical shell of
thickness 0.2a cm and radioactive density rShell= 3 Ci/cm3.
The exposure rates for the sphere alone are also shown in
Figure 10.
The Manchester system prevailed in part because
the energy of Ralston Paterson and in part because
the Manchester physicists of the early 1930s under-
took such detailed studies, publishing the first paper
in 1934 for surface brachytherapy [31], in 1936 for
cylindrical distributions [32], and in 1938 for both in-
terstitial therapy [33] and intracavitary gynaecological
applications [34].
Other attempts such as those of physicist Mayneord
and the surgeon Souttar in London [29] were largely the
work of one person and if only for this reason, could not
compete with Manchester: although both published the
basis of very practical systems.
In both the Manchester and Quimby systems the
planning of an interstitial implant consists of determining
the area or volume of a target region and then referring to
a table or graph for the required total source strength
(milligram-hours) per unit peripheral dose rate [35]. The
Figure 10. Exposure rate along the radii of a combined spherical source with different radioactive
densities, showing an approximate homogeneous exposure rate for the sphere [29]. This represents
a typical study in the period 1930-1935
objective of the interstitial system of Manchester is to
deliver a homogeneous dose throughout the implanted
region or in the treatment plane at 0.5 cm distance for
planar implants.
The Quimby system (always more popular in the
USA than in Europe) called for a uniform distribution of
source strength and accepted the hot spots in the central
region of the implant. The Quimby system prescribed
dose was the same as the peripheral dose [35].
It is also noted that in brachytherapy inverse
planning as well as in many other fields there are several
instances of reinventing the wheel where earlier studies
are ignored and later studies appear to be the first in
their field. One such example is the work of Kneschaurek
et al in 1987 [36] and Xio-Hong W and Potters in 2001
[37]. They reported that for a uniform distribution inside
the sphere the activity density increases rapidly towards
the surface of the sphere where it reaches infinity.
Davison (1950) [38] has solved the problem for
a sphere and infinite cylinder and proved that the density
r of radioactive material within the sphere must be
a simple function of the radius, namely
(13)
where r is the distance from the centre expressed as
a fraction of the radius. Thus the density at the surface
must be infinite to preserve the uniform field. This is the
first exact analytical solution of this important problem
that has been given [39].
To end this brief review it is interesting to relate the
story of Jack Meredith [40], the editor of the standard
Manchester system text [26] and Ralston Paterson's chief
physicist following the departure to the USA of Herbert
Parker. In the early 1930s Paterson had visited Brussels
where work was being undertaken by Murdoch [41] on
a radium System. Paterson was so impressed that he
returned to Manchester with a few sketches, gave these to
Parker and said "This will work, go away and prove it",
which Parker duly did.
C u r r e n t  t h e o r e t i c a l  s t u d i e s  f o r  L D R
b r a c h y t h e r a p y
Alfredo et al [42] used a back-projection algorithm and
idealized ellipsoidal shapes for the PTV to obtain the
activity distribution for an optimal dose distribution.
Theoretical work by Xio-Hong and Potters [37] is
similar to the work of Kneschaurek et al [36], but they
use a more realistic model for the radiation characteristics
of the LDR sources. They examined the minimum
quantity of radioactivity required to deliver a prescribed
dose to a spherical PTV.
The dose rate delivered by a single source [37], is
given by
(14)
where Λ is the dose rate constant, the anisotropy
constant, Sk the air kerma strength and g(r) the radial
dose with the parameterisation g(r)=c1 exp(-m1r)+c2
exp(-m2r). The parameters c1, c2, m1 and m2 are source-
specific.
The integral dose delivered by a single source is
(15)
where T1/2 is the radionuclide half-life. Using a PTV
approximated by a sphere of radius R, the patient integral
dose E is E=p/6R3Dref F, where Dref is the prescribed
uniform dose, F the ratio of patient integral dose to
prostate integral dose. The patient integral dose is defined
as the total energy absorbed in the patient body. This is
the so-called therapeutic ratio.
"When the beam of radiation enters the patient,
energy is absorbed not only in the tumour region but also
in many other places. The total energy absorbed from
the beam is called the integral dose and was originally
defined by Mayneord in 1940 [43, 44]. It is desirable to
keep the integral dose small while an adequate tumour
dose is being delivered. An ideal situation, which can
never be achieved, would be one in which all the absorbed
energy was concentrated in the tumour and none
absorbed elsewhere. This would give the minimum
integral dose for a given tumour dose. The integral dose
to a mass of tissue is the product of the mass of tissue and
the dose which it receives. The unit of integral dose,
defined by Johns & Cunningham in 1969 [45], is the
gram⋅rad, where 1 gm⋅rad=100 ergs".
This definition is just as relevant for brachytherapy.
Although the radioactive sources are generally inside the
tumour region radiation will traverse also normal tissue
and OARs. With the current units, the rad replaced by
cGy and the unit of integral dose is 1 Joule.
For N implanted sources we have
(16)
and the activity per unit dose is
(17)
The question is which continuous source density r(r)
distribution produces the desired dose rate distribution.
This can be solved by considering the integral equation:
(18)
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The equation for a spherical prostate model results
in an inhomogeneous Fredholm integral equation of the
first kind. The solution of this equation can be described
in a nomogram for source dimensions and a therapeutic
ratio of the type F = xRy, with F = 5.3 for 125I (R=4 cm)
and F = 2.7 for 103Pd.
The resulting source density distribution provides
an explanation for the choice of peripheral loading rule
that is necessary to achieve an optimal dose distribution.
Additionally a relationship between the total activity per
unit dose (A) and radius of the sphere (R) is obtained
using A=cRn where A is the total activity required per
unit dose. The results quoted by Xio-Hong and Potters
[37] are A = 0.0098R2.09 U/Gy for 125I and A=0.031R2.25
U/Gy for 103Pd. These parameters were compared to
values recommended by AAPM TG 64 [46], namely (c, n)
= (0.014, 2.05) for 125I and (0.056, 2.22) for 103Pd.
The possibility that the theoretical spherical model
analysis leads to a smaller total activity required to deliver
a prescribed dose when compared to AAPM recom-
mended values is explained by the clusters of radioactive
density in the seeds. Hence we have cold spots due to
intersource spaces and hot spots around the sources,
rather than a uniform spherical distribution of activity.
S t r a t e g y  o p t i o n s  f o r  L D R
b r a c h y t h e r a p y
The strategy options in the 21st century for brachytherapy
using seeds are as follows, using prostate cancer as an
example. They follow directly from the earlier work
starting in the 1930s and are also analytical methods.
– Distribute in the peripheral zone particularly to reduce
the dose around the urethra. Minimum peripheral
dose is used to specify treatment dose.
– Distribute seeds uniformly to minimize cold spots. This
approach could produce high dose values in the centre
of the implant.
– Avoid some of the seeds in the centre of the implant in
order to reduce high dose values. This defines
a modified peripheral loading method.
Some studies, such as that of Butler et al [47] take
the PTV dose distribution as a starting point and compare
the dosimetric results from different loading strategies.
They considered three different peripheral loadings
arrangements and found one of these to be stable to
a certain extent to seed displacement. Basically this was
only a trial and error study.
C o m p u t e r - b a s e d  i n v e r s e  p l a n n i n g  f o r
L D R  b r a c h y t h e r a p y
Starting from the 1930s, inverse planning used
geometrically derived rules to determine how to place
the sources in order to achieve a uniform dose distri-
bution of a specific level in planes, spheres and cylinders.
These rules were obtained by calculating analytically the
dose distribution and by using different source distri-
bution parameters which were varied until an optimal
distribution was obtained.
With the current 3D imaging technologies such
loading/placement strategies are now, in many centres,
altered to accommodate the real 3D anatomy of the PTV
and of the OARs. However, the greatest activity density is
virtually always around the periphery, see Eq. 13, [38].
With the wide availability of personal computers and
the rapidly increasing computer power we have now
entered the new era of computer-based inverse planning in
brachytherapy. This inverse planning is now an optimi-
sation process adapted to the individual geometry of the
patient. Computer-based inverse planning does not
require analytical models for the determination of
a optimal number of sources, catheters and their position.
It also considers various effects such as stability of
solutions for seed misplacements which cannot ever be
solved analytically without gross simplifications.
Initially the optimisation methods used simulated
annealing (SA) and idealised PTV geometries and
ignored OARs. However, new inverse planning optimi-
sation algorithms are anatomy-based. Also, in the last
few years multiobjective inverse planning algorithms have
been developed which recognise the multiobjective
optimisation problem which is inherent in inverse
planning in brachytherapy [11, 12].
I t e r a t i v e  g e o m e t r i c  o p t i m i s a t i o n
Y. Chen et al [48] generate optimised seed distributions by
an iterative algorithm that is used to place one seed at
a single step. The dose distribution in the PTV is
calculated at each step to determine the coldest spot
which is where the next source will to be placed. In this
manner the dose uniformity throughout the PTV is
continually improved as the source placement proceeds.
At each step, the total activity required for the seed
configuration is calculated by normalizing the minimum
dose to the prescribed dose. An optimised configuration
is the one that takes the minimized total activity. That
is, until SMPD has been minimized: where SMPD is the
total source strength required to achieve 1 Gy in the
minimum peripheral dose (MPD).
The minimum total activity required varies only very
slowly with the number of seeds. Hence multiple clinically
acceptable seed configurations with a similar total activity
but with different individual activities are generated using
this geometrical optimisation strategy as shown in Figure
11. The computer generated treatment plans produce
solutions where most of the seeds are distributed in the
periphery of the target. This is a similar result to that
determined by Paterson and Parker in their Manchester
system for rules for a volume implant.
The first seed is placed randomly at an allowed
source location within the specific template geometry.
The doses given by this source with unit strength to all the
points in calculation grid are then calculated. The source
activity is then scaled by matching the minimal dose
within the target volume to the prescribed dose. This
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would be the total activity required if only one seed were
to be implanted.
Next, a second source is placed at a seed location
closest to the coldest spot inside the PTV caused by the
first source. The dose at all calculation points is then
computed for the first two sources, each with unit activity.
This iterative procedure is repeated until some 100 seeds
are positioned within the dimensions of the template.
The total activity is determined by normalizing the
minimum dose to the prescribed dose.
The seed configuration for an actual implantation
is chosen from the sequence generated by iteration such
that the total activity is close to the minimized value and
an available individual activity is matched.
Inverse planning with simulated annealing
Ron Sloboda was the first author to use an SA
algorithm for LDR brachytherapy inverse planning [49,
50]. The square root of a quadratic objective function
was used, including lower and upper dose penalty terms.
Integer parameters were also used and the visiting
probability distribution considers moves such as an
increase or decrease of numbers and/or positions of
sources at a specified set of possible positions. By
including weights at the source positions the method
could also be used for HDR brachytherapy inverse
planning.
Pouliot et al [51] also proposed a SA algorithm for
LDR prostate brachytherapy inverse planning. The
algorithm is described in Figure 12.
The optimisation requires 20,000 iterations.
Empirically determined importance factors are used for
the individual objectives. If the result is not satisfactory
then a new set of importance factors is used and the
optimisation is repeated again. Each optimisation run
requires less than 1 minute.
Figure 12. SA algorithm for LDR inverse planning [51]
Inverse planning with evolutionary algorithms
Yang et al [52] used variants of an elite single objective
genetic algorithm with quadratic dosimetric objective
functions. A small population of 25 members was used for
the GA and single point crossover was performed. The
PTV was approximated by an ellipsoid. Comparisons of
the optimisation results of the GAs were made with
manually optimised implants using as criteria the
conformation number CN and the dose non-uniformity
ratio DNR. If the dose in the urethra was not acceptable
the optimisation was repeated with modifications to the
importance factors until a satisfactory result was achieved.
For a given set of catheters the number of sources and
their optimal position were determined.
Yu and Schell [53] used a single objective genetic
algorithm for idealized elliptical PTV geometries with
half-axes a, b, c and an average dimensional index
d=(a+b+c)/3. The fitness f(i) of the ith individual
combines the number of needles Nn, the PUN and
S10 mPD, i.e. the total source strength to deliver 10 Gy to
the MPD point.
(19)
A, B, D, K are parameters to control the individual
objectives and is the average value of
over the population.
Decision steered algorithm
Yu et al [54] presented an a priori multiobjective GA for
LDR prostate brachytherapy inverse planning. For the
optimisation a total of 11 objectives f1–f11 were defined.
– f1 is the total source strength (U) required achieving
1 Gy of the MPD.
– f2= 1/PUN.
– f3–f5 are the maximum critical dose values to the OARs
(urethra, rectum bladder) normalized to the MPD.
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1. Set allowed needle positions
2. Initial number of seeds based on prostate volume.
Set k = 0 and T = T(0). Generation of an initial seed
configuration S(0).
3. Get initial configuration S and temperature T(0)=T0,
set k=0
4. Select S' successor of S by replacing 1-2 seeds.
5. Calculate ∆E = E(S') – E(S)
6. If ∆E0 then set S = S' else set S = S' with probability
exp(-∆E/T)
7. If equilibrium at current T is reached then go to step 4
else go to step 8
8. k=k+1
9. Reduce T according to the cooling schedule T(k) =
T(0)/k.
10. If stopping criterion satisfied go to step 4 else output
best solution found
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Figure 11. Total source activity required to deliver a specific dose to
the MPD as a function of the number of the seeds implanted, after
Chen et al [48]
– f6–f10 are the expectation values of f3–f5 after random
displacement of seeds from the intended positions.
– f11 is the number of used needles.
A genetic algorithm is used which is guided by
artificial intelligence according to requirements of the
treatment planner [16, 54]. The algorithm modifies the
ranking when goals are achieved by reducing the search
space and increases the search in a specific direction if the
satisfying conditions are not met. A two-dimensional
encoding of the catheter positions is used. The crossover
point is individually selected for each catheter row on
the template. This permits a more flexible exchange than
when using a linear chromosome, see Figure 13.
Ranking among a group of candidate plans is based
on a weighted Lp distance metric. The ideal vector
and anti-deal vector 
are calculated. 
The distance of the ith individual to the ideal and
anti-ideal point using the Lp weighted metric is
and respectively.
(20)
(21)
gj(t) is the metric weight for the jth objective at generation
t. Various values for p, p=1,2,...,∞ have been tested. The
metric is used to rank individuals a higher rank defines
a more preferred plan. The rank of the ith individual
Rp(i) is
(22)
The user is required to present before optimisation
the set of importance factors for the jth objectives Wj and
goals or satisfying conditions G, S for the objectives. If
a goal Gk for the kth objective is satisfied and further
optimisation makes the decision indifferent to the
outcome then is replaced by Gk in the metric . A
satisfying condition Sk is specified if a minimum preferred
level of achievement exists for the kth objective. If the
current best outcome is less preferred to Sk then
gk(t) is increased temporarily by a factor 
.
The function e(t) is taken by Yu et al [16] to be
"realizations of the state energy of the decision system
following a Boltzmann distribution at temperature T(t),
which undergoes thermodynamic cooling, T(t)=T0/(1+t)".
This is analogous to simulated annealing.
The metric weights are gj(t)=Wj+uj(t) where uj(t) is
a normal distributed random variable with mean=0 and
variance . This approach considers 
the judgment and preferences of a treatment planner.
Objectives f6–f10 are included to solutions that are more
robust to seed misplacements.
The algorithm is shown in Figure 14. A population of
64 individuals is selected and random activity loadings
for the catheters are selected, including preferentially
peripheral patterns.
A stopping criterion considers if after some specified
number of iterations no improvement is observed. The
selection method uses a dynamic tournament scenario in
which the number of parents used for the selection
increases periodically during the optimisation, therefore
increasing the selection pressure.
Figure 14. GA inverse planning algorithm for LDR, after Yu et al. [54]
The ranking of the individuals is described in Figure 15.
1. Initialise population with random loading patterns.
2. Evaluate dosimetry for each individual.
3. Rank individuals according to a multiobjective metric
(see Figure 15).
4. Perform a dynamic n-Tournament. The n best individuals
are selected for reproduction. This number increases
periodically by one unit reaching finally 25% of the
population size.
5. Perform crossover.
6. Perform a flip mutation. If a catheter is selected for
mutation its on/off status is flipped.
7. If generation maximum reached or other criterion is
satisfied output solution else go to 2.
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Figure 13. Crossover of the two-dimensional chromosome for template
based LDR inverse planning using the method proposed by Yu et al
[54]. The individual parent solutions P1 and P2 after crossover produce
the children solutions C1 and C2. The contours of the PTV are
projected onto the template plane
Inverse planning with mixed integer programming
A linear mixed integer programming MIP algorithm was
proposed by Lee et al [55] for LDR prostate brachy-
therapy inverse planning. A system of linear constraints is
imposed which attempts to keep the dose level at each
sampling point to within specified bounds. A grid of
possible seed placement positions is considered and the
parameters 0/1 at these specify a placement or not of
a seed. These are the integer parameters of the problem.
Constraints of dose values define the real continuous
parameters of the problem. Each constraint uses
a variable that either records if the desired constraint is
satisfied, or the degree of the constraint violation. These
additional variables are embedded into an objective
function to be optimised. Two methods were used for the
optimisation: (i) a branch and bound algorithm and (ii)
a genetic algorithm.
Results of both methods for a data set of 20 prostate
tumour cases indicate that both optimisation algorithms
are capable of producing good solutions in 5-15 min. It
was also found that small variations in model parameters
can have a measurable effect on the dose distribution of
the resulting plans [55].
In this study the authors let
be the dose at point P. d
~
Pj is the dose contribution of the
jth seed position to the point P, xj0/1 variables indicating
the presence of a seed at the jth possible seed position. Let
Lp and Up be the upper and lower dose value bounds
desired at the point P. The following constraints are
considered.
d(P)+Np(1–vP)Lp (23)
d(P)+Mp(1–wP)Up (24)
Positive constant terms Mp, Np are included for the
lower and upper bound, vP and wP are 0/1 variables. If
vP=1 can be found then the lower bound constraint is
satisfied and for wP=1 also the upper bound. The
objective is to maximize the number of points which
satisfy the lower and upper constraints i.e. maximize
ΣP(vP+wP).
As it may difficult to satisfy constraints for some
points a weighted sum can be used, and the objective is to
maximize
ΣP(aPvP+bPwP) (25)
where(aP,bP) are non-negative real parameters.
In the second approach Lee et al [55] considered
the deviation of the dose level at each point P from its
bounds yp, zp are continuous parameters that are used
the describe the violation of the constraints
d(P)+ypLp (26)
d(P)–zpUp (27)
The objective is to minimize the weighted sum of
deviations
ΣP(aPyP+bPzP) (28)
where (aP,bP) are non-negative real parameters.
Souza et al [56] also proposed an MIP algorithm and
the branch and bound method for LDR prostate
brachytherapy inverse planning. Dose optimisation
constraints were imposed on a very fine dose grid (1 mm)
within the target and OARs. In three-dimensions the
number of continuous variables (dose calculation points)
within the prostate alone exceeded 10,000, while the total
number of dose points in the ultrasound image exceeds
100,000.
The fine sampling of the space in which dose is
calculated leads to a large and complex mathematical
model that is difficult to be solved as a three-dimensional
problem. Even with state of the art branch and bound
software it is not possible to solve the corresponding 3D
mixed integer model. An iterative sequential optimisation
method was developed, in which the seed placements
within 2D ultrasound slices (planes) is optimised, taking
into account dose contributions from neighbouring
planes. 
Within each 2D ultrasound image plane there are
156 potential implantation sites. However, since seeds
can only be placed within the PTV, this number is reduced
to 30-60 seed implantation sites per plane. Therefore the
0/1 (where 0 indicates there is no seed implanted and 1
indicates that there is a seed implanted) seed placement
parameter must be determined for approximately 450-800
places in the template. This corresponds to the possible
implantation sites over the entire PTV. There are typically
10-15 planes. With this method it is possible to obtain
solutions in 20-45 min using a 200 MHz processor.
A comparison with a manual trial and error
approach shows that the optimised plans are generally
superior. If the dose to the urethra is undesirably high,
a refined optimisation approach is used that lowers
urethra dose without significant loss in target coverage.
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1. Evaluate N individuals of M-tuples of objectives fj(i),
i=1,...,N and j=1,..., M
2. For all M objectives calculate and .
3. For all M objectives set gj(t)
4. For all j=1,..., M objectives if Sj is defined and preferred 
to set gj(t)=B(t)gj(t)
5. For all j=1,..., M objectives if Gj is defined set .
6. Compute 
7. Compute Rp(i), i=1,..., N
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Figure 15. Ranking of the individuals
The latter approach requires 5-10 min of additional
computing time, much less than the manual approach
with an average planning time of 2.5 hours.
Souza et al [56] implies that an analysis of the
sensitivity of the optimised plans to seed misplacement
during the implantation process indicates a remarkable
stability of the dose distribution in comparison to manual
treatment plans.
HDR brachytherapy
In HDR brachytherapy the optimal position of catheters
and their position have to be found. For this process, the
optimisation has to consider combinations of 5-20
catheters from a set of up to 60 possible catheters. For
each catheter more than 20 source-dwell positions could
exist. Additionally to the catheters the optimum dwell
times at the dwell positions of each selected catheter have
to be found.
The combinatorial complexity of this problem is
extremely high. In LDR brachytherapy the seed sources
are usually of the same activity. However, in HDR
brachytherapy the variable dwell time produce a large
number of solutions with different numbers and positions
of catheters but with similar dose distributions. It should
also be emphasised that the variation of the LDR seed
positions in permanent brachytherapy and other effects
such as post-implant oedema can greatly influence the
final dose distribution and reduce the quality of the LDR
results obtained by inverse planning.
Changes of source positions after implantation in
HDR brachytherapy from the positions used in inverse
planning are less important as modifications of the dwell
times from post-planning optimisation can to some extent
compensate for these factors.
We limit our discussion to the case where the
possible catheter positions are defined by a template,
usually by coordinates on a rectangular grid. We ignore
the problem of the case where the catheters are not
parallel to each other and have been positioned by free-
hand implantation.
E m p i r i c a l  l o a d i n g  m e t h o d s
The use of empirical derived methods is very common
for the selection of catheters. Similar to the LDR
brachytherapy situation, these HDR methods use
a majority of peripherally placed catheters in order to
achieve a uniform dose distribution. Sometimes the term
modified peripheral is employed to infer that the PTV is
large enough to justify a few centrally placed catheters.
The William Beaumont template-based method
(WBT), [57] for inverse HDR prostate planning is one
such an empirical method, derived from the analysis of
a large number of clinical implants.
The catheter placements consider the reference
plane lying between the base plane and apex and it is
normally the plane with the largest prostate cross-
sectional contour. The WBT method considers the
geometrical dose optimisation method to be a basis for
dose optimisation: the results strongly depend on the
catheter geometry. The original WBT method assumes
a cylindrical prostate geometry.
The prostate is defined on the reference plane and
this contour is extrapolated and expanded between the
base plane and the apex. Some parameters that must be
specified are the distances between the peripheral
catheters, and the urethra avoidance distance that
catheters should have from the urethra.
The area and prostate perimeter at the reference
plane defines the number and the position of internal
catheters that will be placed additionally to the peripheral
catheters. Depending on the prostate area 0, 2, 4 or 5
interior/central catheters are inserted additionally to the
peripheral catheters. Their position is determined
depending on their number, using the centre of the area
and the bounding rectangle of the prostate contour.
C o m p u t e r  b a s e d  m e t h o d s
Multiobjective evolutionary inverse planning
For HDR brachytherapy inverse planning it is more
natural to use multiobjective evolutionary algorithms
(MOEAs) to obtain a representative set of non-
dominated solutions rather than only a single solution.
The following set of objectives was used:
– as the fraction of PTV 
with a dose value 
– as the fraction of PTV 
with 
– as the fraction for the 
jth OAR with 
– as the average squared dose in the 
surrounding normal tissue
– fN=NC as the number of catheters NC.
is the prescription dose, or lower dose limit
and is the high dose limit in the PTV. fNT is the mean
quadratic dose in the surrounding normal tissue. NPTV,
NNT and are the number of sampling points in the
PTV, normal tissue and in the jth OAR. The objectives,
, and are proportional to the DVH
values at the corresponding dose values.
The advantage of using these objectives is that the
results in terms of objective values are more intuitive to
understand than other objectives. The use of the square of
the dose value ensures that high dose values are more
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likely to be avoided in the NT than are the more
uniformly distributed moderate dose values. For we
use a value of 1.5 times the prescription dose. The dose is
not normalized on any particular point or set of points.
In addition to the dosimetric objectives, the
additional objective of the number of catheters is also
included.
An automatic template-based catheter placement
algorithm has been developed by Baltas and Lahanas for
inverse planning in HDR brachytherapy. The algorithm
determines from the anatomical structures, PTV and
OARs which catheters and to what depth in the PTV
they should be inserted, given a minimum distance to the
PTV surface and OARs.
The part of each catheter that is inside the PTV can
be adjusted individually according to the anatomy. The
part of catheter that remains free in front of the template
is called the free length and has to be at least as large as
the afterloading system-dependent minimum free length.
This is to ensure that the catheter can be connected to the
transfer tube.
The adjustment of the catheter position (depth) at
a specific template hole is performed by checking the
minimum distance between the first dwell position of the
catheter and the organ surfaces (PTV and selected
OARs). That distance should be larger than a specified
lower limit. The first SDP (the one that is closer to the
catheter tip) must always be a feasible SDP. This means it
must fulfil the above constraint. However, if the maximum
number of potential active SDPs on a catheter is smaller
than a specified minimum, the catheter will be rejected.
Hybrid evolutionary multiobjective optimisation
For the inverse planning we use a modified version of an
algorithm proposed by Lahanas et al [12] for dose
optimisation.
The MOEA is supported by a deterministic gradient-
based optimisation algorithm and provides
a representative set of non-dominated solutions. This set
contains information for the treatment planner, such as
how the results depend on the number of the catheters,
the spectrum of DVHs for the PTV and the OARs.
Additionally the corresponding trade-off between the
objectives and the limitations of the dose distributions
can be extracted. This data is used for the selection of
a solution with a optimal number of catheters, their
position and the smallest compromise on the individual
objectives.
The initial random generated NSGA-II population
moves fast towards the global Pareto front but slows down
providing only a local Pareto front, see Figure 16. The
global Pareto front can be reached if at all only
asymptotically after a very large number of generations.
If a small number of individuals are moved on the
global Pareto front, see Figure 16, using an efficient
optimisation algorithm, then they efficiently attract the
other individuals in their neighbourhood. These so-called
supporting solutions [58, 59] improve very significantly the
performance of MOEAs and enable a fast accumulation
of solutions close to the global Pareto front. A
combination of NSGA-II with a deterministic algorithm
improves the diversity along the front and guides the
population closer and faster towards the global Pareto
front.
If the Pareto front is very large then for a small
population, some important parts of the Pareto surface
may not be occupied. It is possible to use constraints
which allow restricting the population into parts of the
objective space which are of particular interest. Such
a constraint when used for the DVH-based objectives is
, i.e. only solutions with a PTV coverage of at
least 70% are considered. An archiving method in which
an external population is filled with all the non-dominated
solutions found can be used to accumulate a sufficient
large number of solutions.
At each generation, each solution of the genetic
population is compared with all the individuals of the
external population. If a solution for the genetic pool
dominates solutions for the external population and if it is
non-dominated by them then it is added to the external
pool and all the dominated solutions are removed. If the
population has reached its maximum size, as set by the
user, then the non-dominated solution replaces a solution
that has the highest number of individuals in its
neighbourhood.
This mechanism prevents accumulation of solutions
in a part of the objective space and allows a more uniform
coverage of the Pareto front by the archived solutions.
The non-domination tests usually require much less time
than the function evaluation and the non-dominated
sorting. More than thousand non-dominated solutions
can be acquired in 100 generations in one minute.
Encoding
For the inverse planning problem encoding a two-
component chromosome is used. The first part W
contains the dwell times of all dwell positions with
a double precision floating-point representation. The
second part C is a binary string which represents the
catheters which have been selected: the so-called active
catheters. The SDPs of the active catheters are called
active SDPs.
Figure 16 shows the encoding for a five-catheter
case. The dwell times of each catheter is saved in the
arrays w1,...,w5. The catheter part encodes the case where
catheters 2, 4 and 5 have been selected.
Figure 16. Encoding of the chromosomes for an imaginary treatment
case with five possible catheters out of which three are used
< .f 0 3L
PTV
DH
V
213
CW
Genetic operators
For the chromosome part W two crossover operators are
used. For W a SBX crossover operator is used. For the
second part C a two-point crossover operator and a flip
mutation is used. A repair mechanism keeps the number
of selected catheters inside a user specific range.
Tests with implants using the same importance
factors but with a different number of SDPs show that
the sum of the dwell times of all sources is almost
constant. In the crossover of dwell times between
solutions with a different number of active source-dwell
positions we have to consider that the average dwell time
is inversely proportional to the number of SDPs in the
active catheters.
The exchanged information from crossover between
individuals with different numbers of active SDPs has to
be made independent of the number of active SDPs.
Therefore the weights of each population member are
multiplied by the number of active dwells decoded in the
catheter chromosome. After the crossover the mutation is
applied. This may change not only the catheter topology
but also the number of catheters.
The weights after the genetic operations are divided
by the actual number of active SDPS encoded in the
catheter chromosome so that the dwell times depend on
the number of active SDPs. Without this modification
before the crossover and after the mutation, only
solutions with the smallest possible number of allowed
SDPs would be accumulated. Individuals with a larger
number of active SDPs would contain after crossover the
dwell times obtained by solutions with a smaller number
of sources which are too high for these solutions. The
resulting variances would so large that these individuals
would not be selected.
A multiobjective evolutionary optimisation algorithm
is used, see Figure 17. The user specifies a range of
number of catheters to be considered. The optimisation
algorithm requires 1-2 minutes on a 1.4 GHz PC to obtain
a representative set of up to 100 solutions. Constraints are
applied on the resulting solutions to avoid clinical not
acceptable solutions.
Figure 17. MOEA inverse planning for HDR brachytherapy
The analysis of these solutions, calculation of DVHs,
and other dosimetric quantities such as COIN distri-
butions and natural dose-volume histograms requires
additional one minute. Decision making tools are used to
analyse the trade-off between the objectives, compare
DVHs of the PTV and the OARs and analyse range of
dosimetric values. This information is used by a treatment
planner to select the solution with the smallest
compromise on the various objectives and which satisfies
as best as possible clinical defined constraints.
I s  i n v e r s e  p l a n n i n g  f o r  H D R
b r a c h y t h e r a p y  r e a l l y  n e c e s s a r y ?
For HDR brachytherapy the optimisation of dwell times
allows the optimisation of dose distribution even if the
catheter and SDP geometry are not exactly as used in
the inverse planning. Is inverse planning for HDR
brachytherapy therefore really necessary?
Dose optimisation was performed by a treatment
planner using the Nucletron PLATO treatment planning
system. Three HDR plans were created with respectively
4, 10 and 16 catheters. The position of the catheters was
determined by a trial and error method.
The HDR results were compared with those for
a LDR plan using 29 catheters. They show that a large
number of catheters are not necessarily a guarantee of
a good optimisation, see Figure 18. Increasing the number
of catheters and SDPs produces by geometric optimi-
sation a number of hot spots. From dose point optimisa-
tion algorithms, by increasing the number of catheters, the
number of negative dwells is increased and this reduces
the quality of the solutions. The catheter position is
important if good solutions with a small number of
catheters have to be found. The dwell times cannot
compensate for non-optimal catheter placements.
Tests show that the number of catheters can be
reduced significantly without any important modification
of the dose distribution. Inverse planning offers the
possibility to reduce the number of catheters and simplify
the treatment plan. MOEA inverse planning also offers
important information for the selection of the best
solution.
W h a t  c a n  w e  l e a r n  f r o m  m u l t i o b j e c t i v e
i n v e r s e  p l a n n i n g ?
Multiobjective inverse planning offers a spectrum of
possibilities and allows better understanding of the
limitations and differences of optimisation methods. In
the past, comparisons of different optimisation methods
were made which were based on single solutions selected
with some set of importance factors.
In LDR brachytherapy studies considered the
differing results using 125I and 103Pd seeds. Despite their
energy and half-life differences no conclusions have been
made in terms of clinical benefits for 125I versus 103Pd.
Cha et al [60] did not observe any difference in
clinical effectiveness but mentioned that there is
1. Determine set of all allowed catheters.
2. Initialise individuals with solutions from a global
optimisation algorithm.
3. Selection based on constrained domination ranking.
4. Perform a SBX crossover for the SDP weights chromo-
some and one point crossover for the catheter chromo-
some with rescaled dwell times.
5. Perform a polynomial mutation for the SDP weights
chromosome and flip mutation for the catheter
chromosome with rescaled dwell times.
6. Perform a repair mechanism to set the number of used
catheters of each solution in a given range.
7. Reset scaling according to number of active SDPs.
8. Evaluate dosimetry for each individual.
9. If generation maximum or other criterion is satisfied
output set of non-dominated solutions else go to 3.
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a considerable variability in the delineation of tumour
volume and implant quality depending on the treatment
planner. This makes conclusions difficult.
As the trade-off between the objectives is not known
by the single objective optimisation algorithms used in
the past we cannot say how good is a given solution as we
do not know what part of the Pareto front it represents.
Multiobjective optimisation offers this knowledge and as
an example we examine how and if the solutions depend
on the characteristics of a source for HDR brachytherapy.
Optimal sources for optimal results
The dose distribution depends on the characteristics
of the sources, such as type of emitted radiation, its
energy spectrum and the geometry of the source,
including the material such as the encapsulation of the
source. Even if there is a dominant inverse square
dependence on the dose in brachytherapy, the possible
dose distributions which can be obtained depend on the
physical characteristics of the sources. The radial dose
function g(r) for various monoenergetic point sources is
shown in Figure 19(a). The radial distribution for a point
source for various isotopes taking the mean energy is
shown in Figure 19(b).
We consider monoenergetic point sources and the
dependence of the optimisation results on the energy of
the sources. For a prostate implant with 15 catheters we
studied a multiobjective optimisation. The spectrum of
solutions from a representative set of 100 non-dominated
solutions is shown in Figure 20 for the PTV and the
urethra for two monoenergetic point sources with photons
energy of 20 and 40 keV.
Figure 21 shows the V150 and D90 range for the PTV
and the D10 range for the urethra. The spectrum of
solutions from a representative set of 100 non-dominated
solutions is shown in Figure 21 for the PTV and the
urethra for 192Ir and a monoenergetic point source with
photon energy of 100 keV.
The results demonstrate that optimisation results
can differ and some solutions which can be obtained by
one source type are not available from other types of
sources. The results show that the characteristic
properties of the sources are important.
Multiobjective dose optimisation is important
in order to obtain a better understanding of the limita-
tions and possibilities of dose optimisation in brachy-
therapy. Taking only a single solution by a single objective
dose optimisation algorithm would not give this infor-
mation.
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Figure 18.dFigure 18.c
Figure 18. DVHs for (a) the PTV, (b) urethra, (c) bladder and (d) rectum for a prostate tumour patient. The results of an HDR dose optimisation
using 4, 10 and 16 catheters are shown. The HDR results are compared with those for LDR brachytherapy with 29 catheters and 74 seeds
Figure 18.bFigure 18.a
The dose distributions that can be obtained depend
not only on the position of the sources or SDPs but also
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Figure 21a
Figure 21. Spectrum of DVHs for the PTV and the urethra for a prostate implant from solutions obtained by multiobjective dose optimisation for
monoenergetic point sources with photon energy of 100 keV and for a 192Ir source
Figure 21b
Figure 20a
Figure 20. Spectrum of DVHs for the PTV and the urethra for a prostate implant from solutions obtained by multiobjective dose optimisation for
monoenergetic point sources with photon energy of 20 and 40 keV
Figure 20b
Figure 19a
Figure 19. Radial dose function g(r) for points sources (a) for various photon energies and (b) for various isotopes
Figure 19b
on the energy spectrum. Considering this in inverse
planning additional to the catheter geometry and the
number of sources could lead to a generalized multi-
objective inverse planning which can further improve the
dose distributions that can be obtained.
Conclusions
Inverse planning in brachytherapy has entered a new era
where previous empirical methods will be replaced by
automatic computerized methods. The speed of current
computers allows for the first time, users to obtain
solutions adapted to the real anatomy of the tumour
and the OARs. With multiobjective optimisation it is
possible to obtain information that can be used to obtain
the optimum number of catheters, their position and
the optimum distribution of dwell times for HDR
brachytherapy. For LDR brachytherapy also the sta-
bility of solutions due to seed migration can also be im-
proved.
Treatment planners may require some time to
abandon some of the methods they learnt to use and
training and start to use inverse planning in the clinical
routine. This is in part a philosophical problem because
planners are not used to consider inverse problems.
With multiobjective optimisation a spectrum of
alternative solutions is available and the treatment
planner can select the solution that best satisfies the
clinical constraints. All computer-based inverse planning
methods provide better dose distributions that can be
obtained by experienced planners.
More important than the gain of quality by
multiobjective inverse planning is that the planners will
recognize that empirical methods require a much larger
time to obtain a satisfactory solution requiring adjust-
ments of the catheter positions than the automatic
adaptive inverse planning methods.
Tools have been developed for computer tomo-
graphy [61] and recently 3D-ultrasound imaging based
brachytherapy [62, 63] that allows the very fast automatic
or semiautomatic accurate definition of the PTV and
OARs together with a fast reconstruction of the catheters.
Conformal anatomy-based dose optimisation allows the
prescription of higher dose values and requires modern
three-dimensional imaging-based brachytherapy.
This reduces the overall treatment time significantly
allowing the treatment of more patients and reducing the
cost implications. In 21st century medicine this is a very
important factor and one which should not be ignored
when developing new ideas.
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